cjc 1295 and ipamorelin blend CJC-1295 / CJC-1295 & Ipamorelin Blend Research

doi: 10.17576/jsm-2021-5007-12 137 Di FranciaRCrisciSDe MonacoACafieroCReAIaccarinoGet al

Wu C, Luan H, Zhang X, et al

A 2003 study by Staresinic, Sebecic, Patrlj, and colleagues in Journal of Orthopaedic Research used a rat Achilles tendon transection model with BPC-157 administered intraperitoneally once daily at 10 g/kg, 10 ng/kg, or 10 pg/kg and reported improved load-to-failure, Young's modulus of elasticity, and Achilles functional index scores, reduced tendon defect size by day 14, and increased tendocyte outgrowth in vitro with specific numerical effect sizes and p-values not reported in the abstract

BPC-157 is not FDA-approved for human therapeutic use